Publications Database

Geier D. A. et al. (2011)

A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.

Medical Science Monitor

17(6), pp. 15-123

Read Abstract (New Window)

Geier D. A. et al. (2008)

A prospective study of transsulfuration biomarkers in autistic disorders.

Neurochemical Research

34(2), pp. 386-393

Read Abstract (New Window)

Geier D. A. et al. (2008)

Biomarkers of environmental toxicity and susceptibility in autism.

Journal of the Neurological Sciences

280(1), pp. 101-108

Read Abstract (New Window)

Kern J. K. et al. (2011)

A clinical trial of glutathione supplementation in autism spectrum disorders.

Medical Science Monitor

17(12),

Read Abstract (New Window)

Kern J. K. et al. (2001)

Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder.

Journal of Child Neurology

16(3), pp. 169-173

Read Abstract (New Window)

Kern J. K. et al. (2002)

Efficacy of porcine secretin in children with autism and pervasive developmental disorder.

Journal of Autism and Developmental Disorders

32(3),

Read Abstract (New Window)

Kern J. K. et al. (2011)

Prospective trial of equine-assisted activities in autism spectrum disorder.

Alternative Therapies in Health and Medicine

17(3),

Read Abstract (New Window)

Kern J. K. et al. (2013)

Prospective, blinded exploratory evaluation of the PlayWisely program in children with autism spectrum disorder.

Yale Journal of Biology and Medicine

86(2), pp. 157-167.

Read Abstract (New Window) Read Full (New Window)

Kern J. K. et al. (2007)

Sulfhydryl-reactive metals in autism.

Journal of Toxicology and Environmental Health (Part A)

70(8), pp. 715-721.

Read Abstract (New Window)

Kern J. K. , Espinoza E. , Trivedi M. H. (2004)

The effectiveness of secretin in the management of autism.

Expert Opinion on Pharmacotherapy

5(2),

Read Abstract (New Window)